# Senior Appointment at Takeda Turkey

> Takeda, a Japan-headquartered global biopharmaceutical company, has announced the appointment of Sumito Soichi as Country Leader for Takeda Turkey, effective October 15, 2026. Bringing over 13 years of executive experience across Takeda's operations in Japan, Europe, and the United States, Soichi will lead the company’s commercial operations and therapeutic portfolio in Turkey.

Published: 2026-10-15T07:57:00+00:00
Language: en
Categories: [Prices](https://chemexworld.com/en/categories/business-world-markets/prices.md), [R&D](https://chemexworld.com/en/categories/research/rd.md)

Canonical URL:
https://chemexworld.com/en/news/senior-appointment-at-takeda-turkey

## Content

With an institutional heritage spanning 245 years, Takeda aligns its executive leadership in Turkey to expand patient access across core therapeutic pillars: gastroenterology, rare diseases, plasma-derived therapies, oncology, and neuroscience. Prior to his current appointment, Soichi served as Director of the global CEO Office, supporting enterprise-wide strategic execution.

### Professional Background of Sumito Soichi

- **Academic Background:** Soichi holds a Bachelor’s degree in Economics and Finance from Hiroshima University in Japan and an MBA from IE Business School in Spain.
- **Career Trajectory:** Joining the biopharmaceutical sector in 2013, Soichi has dedicated more than 13 years to Takeda across various geographic markets. His expertise spans commercial operations, market access, business development, corporate strategy, and digital healthcare transformation.
- **Key Leadership Roles:** Soichi previously served as Head of Business Operations for Takeda Poland before transitioning to the US Business Unit to lead critical market access initiatives. Most recently, he served as Director of the CEO Office, steering corporate strategic initiatives.

As of October 15, 2026, Sumito Soichi assumes executive oversight of Takeda Turkey, leading the organization to accelerate the availability of innovative pharmaceutical solutions across the domestic healthcare ecosystem.

**About Takeda**

Founded in 1781 in Japan, Takeda is a research and development-driven global biopharmaceutical company focusing on gastroenterology, rare diseases, plasma-derived therapies, oncology, neuroscience, and vaccines. Operating across approximately 80 countries, Takeda delivers science-based treatments to improve health outcomes globally.